Published in J Biol Chem on October 13, 2000
Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol (2004) 4.08
Activation and activities of the p53 tumour suppressor protein. Br J Cancer (2001) 1.90
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J (2003) 1.85
The MDM2-p53 pathway revisited. J Biomed Res (2013) 1.52
The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/SNF complexes. Nucleic Acids Res (2004) 1.21
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol (2009) 1.18
Regulation of p53 and MDM2 activity by MTBP. Mol Cell Biol (2005) 1.05
Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest. Mol Cell Biol (2007) 1.01
MdmX regulates transformation and chromosomal stability in p53-deficient cells. Cell Cycle (2008) 0.95
MDM2 regulates dihydrofolate reductase activity through monoubiquitination. Cancer Res (2008) 0.95
MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene (2012) 0.94
MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival. Mol Cancer Res (2014) 0.92
Oncogenic protein MTBP interacts with MYC to promote tumorigenesis. Cancer Res (2014) 0.90
A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene (2010) 0.90
MTBP plays a crucial role in mitotic progression and chromosome segregation. Cell Death Differ (2011) 0.89
Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination. FEBS Lett (2010) 0.86
Splicing up mdm2 for cancer proteome diversity. Genes Cancer (2012) 0.85
Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo. PLoS One (2012) 0.84
miR-150 inhibits terminal erythroid proliferation and differentiation. Oncotarget (2015) 0.81
A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene. Nucleic Acids Res (2003) 0.80
MTBP inhibits migration and metastasis of hepatocellular carcinoma. Clin Exp Metastasis (2015) 0.77
Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex. Cancers (Basel) (2014) 0.76
MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin. Dig Dis Sci (2015) 0.76
Structural Exploration and Conformational Transitions in MDM2 upon DHFR Interaction from Homo sapiens: A Computational Outlook for Malignancy via Epigenetic Disruption. Scientifica (Cairo) (2016) 0.75
Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer. Oncoimmunology (2016) 0.75
Bridge-Induced Translocation between NUP145 and TOP2 Yeast Genes Models the Genetic Fusion between the Human Orthologs Associated With Acute Myeloid Leukemia. Front Oncol (2017) 0.75
Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis. Hepatoma Res (2016) 0.75
A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol (1977) 1.43
Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene (1994) 1.40
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Blood (1996) 1.02
Familial hyperglycerolemia. J Clin Invest (1978) 1.01
MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase epsilon. Nucleic Acids Res (2000) 0.93
Extraction of cellular DNA from crude cell lysate with glass. Nucleic Acids Res (1990) 0.92
A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene (2010) 0.90
The pathway regulating MDM2 protein degradation can be altered in human leukemic cells. Cancer Res (1999) 0.89
Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone. J Allergy Clin Immunol (1978) 0.88
Identification of a tumor-derived p53 mutant with novel transactivating selectivity. Oncogene (2000) 0.84
Interleukin-1 alpha mediates an alternative pathway for the antiproliferative action of poly(I.C) on human endothelial cells. J Biol Chem (1992) 0.84
Short-term administration of dimercaptopropanol (BAL) and calcium disodium edetate (EDTA) for diagnostic and therapeutic lead mobilization. Int J Biochem (1980) 0.84
A simple method for the determination of gold in serum, blood, and urine by atomic absorption spectroscopy. Am J Clin Pathol (1973) 0.83
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. J Clin Oncol (1997) 0.83
Expression of 14-3-3 gamma in injured arteries and growth factor- and cytokine-stimulated human vascular smooth muscle cells. Cell Growth Differ (1996) 0.82
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome. Br J Haematol (1996) 0.81
Impaired labelling of liver phosphatidylethanolamine from ethanolamine-14C in choline deficiency. Can J Biochem (1970) 0.80
mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells. Oncogene (1998) 0.78
Occupational lead exposure: studies in two brothers showing differential susceptibility to lead. Clin Biochem (1985) 0.77
Retraction for D. R. Zweitzig, N. Shcherbik, and D. S. Haines: AAA ATPase P97 and adaptor UBXD1 suppress MDM2 ubiquitination and degradation and promote constitutive P53 turnover. Mol Biol Cell (2008) 0.77
The effects of choline deficiency and choline re-feeding upon the metabolism of plasma and liver lipids. Can J Biochem (1966) 0.77
Pulmonary phosphatidylcholine biosynthesis. Alterations in the pool sizes of choline and choline derivatives in rabbit fetal lung during development. Biochim Biophys Acta (1981) 0.75
Increased catabolism of phosphatidylcholine to betaine regulates the liver phosphatidylcholine content in rats fed orotic acid. Biochem Int (1989) 0.75
Influence of choline deficiency upon the hyperlipemia of alloxan-diabetic rats. Diabetes (1965) 0.75
Interference in assay of free triiodothyronine by triiodothyronine-binding antibodies. Clin Chem (1991) 0.75
Actions of dietary orotic acid on liver synthesis of phosphatidylcholine and phosphatidylethanolamine in rats. Biochem Cell Biol (1987) 0.75
Assignment of the MDM2 binding protein gene (MTBP) to human chromosome band 8q24 by in situ hybridization. Cytogenet Cell Genet (2000) 0.75
Changes in metabolism of ethanolamine and its derivatives in liver during fasting. Can J Biochem (1975) 0.75
The influence of dietary choline intake upon liver ethanolamine metabolism. Can J Biochem (1979) 0.75
Cholesterol granulomas in lymph nodes draining a benign ovarian neoplasm. Arch Pathol Lab Med (1985) 0.75
Early effects of dietary orotic acid upon liver lipid synthesis and bile cholesterol secretion in rats. J Lipid Res (1985) 0.75
Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy. Cancer Prev Control (1999) 0.75
Clinical evaluation of serum thyroglobulin measurement using a commercial kit in the diagnosis of recurrent thyroid cancer. Clin Biochem (1989) 0.75